A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
May 26, 2017
|
| In: |
Blood
Year: 2017, Volume: 130, Issue: 5, Pages: 597-605 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2017-03-771220 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1182/blood-2017-03-771220
|
| Author Notes: | Vaishali Sanchorawala, Giovanni Palladini, Vishal Kukreti, Jeffrey A. Zonder, Adam D. Cohen, David C. Seldin, Angela Dispenzieri, Arnaud Jaccard, Stefan O. Schönland, Deborah Berg, Huyuan Yang, Neeraj Gupta, Ai-Min Hui, Raymond L. Comenzo and Giampaolo Merlini |
| Item Description: | Prepublished online as Blood First Edition paper, 26 May 2017 Gesehen am 15.08.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2017-03-771220 |